Johnson & Johnson Launches ‚Heartline Study‘ to Explore if iPhone and Apple Watch Can Reduce Risk of Stroke


Johnson & Johnson, in collaboration with Apple, has announced that enrollment for a new Heartline Study is now open. The study will explore if a new Heartline app for iPhone and the Apple Watch can reduce the risk of stroke with earlier detection of atrial fibrillation (AFib).
To enroll in the Heartline Study, individuals must be age 65 or older, a U.S. resident, have Original (traditional) Medicare, own an iPhone 6s or a later model, and agree to provide access to their Medicare claims data.
"Heartline is a study that has the potential to fundamentally change our understanding of how digital health tools, like the ECG app and irregular rhythm notification feature on Apple Watch, could lead to earlier detection of AFib, helping patients understand and directly engage in their heart health, prompting potentially life-saving conversations with their doctors, and improving health outcomes," notes Dr. C. Michael Gibson, Co-Chair of the Heartline Executive Committee and Professor of Medicine, Harvard Medical School and CEO, Baim Institute.

Spotlight Deal:
Apple 27-inch 5K iMac On Sale for $200 Off [Deal]
Share Article:
Facebook, Twitter, LinkedIn, Email, Reddit, Digg, Delicious, StumbleUpon
Follow iClarified:
Facebook, Twitter, LinkedIn, Newsletter, App Store, YouTube

You Might Also Like